Skip to content
Britain’s £3.52 billion Health Security Campus will unite 2,500 specialists by 2038, creating advanced containment laboratories for infectious-disease research and preparedness.
The UK is set to invest £3.52 billion in a new Health Security Campus designed to strengthen the country’s capacity for infectious-disease research, surveillance and emergency preparedness.
Planned for completion by 2038, the campus will bring together specialist teams and scientific facilities currently spread across several legacy sites. Around 2,500 expert roles are expected to transfer into a more integrated environment, creating a central hub for work on infectious diseases and other biological threats.
The programme reflects the growing importance of resilient laboratory infrastructure in protecting public health. Recent global health emergencies have demonstrated the need for facilities that can support rapid research, diagnostic development, pathogen characterisation and coordinated scientific responses when new threats emerge.
A key element of the development is the H50 High Containment Building. The facility will include advanced Containment Level 3 and Containment Level 4 laboratories, providing secure environments for research involving high-risk pathogens. Its planned suited CL4 laboratories will use air-fed suits, offering researchers flexibility to carry out a wider range of scientific activities while maintaining the highest levels of biosafety and biosecurity.
The campus will also include a main building with additional laboratory capacity across Containment Level 2, CL3 SAPO 3 and CL3 SAPO 4 classifications, alongside office and collaboration spaces. Bringing these capabilities together is expected to support more efficient workflows, shared expertise and closer collaboration across disciplines.
For laboratory professionals, the programme is a significant example of how national research infrastructure is evolving. High-containment facilities require specialist design, validated equipment, rigorous operational procedures and highly trained teams. The development will therefore have implications across laboratory engineering, safety, automation, data management, procurement and workforce development.
Consolidating operations into a single campus could also make it easier to connect research activity with public-health decision-making. Faster access to specialist laboratory capability, combined with coordinated scientific expertise, may help the UK respond more effectively to emerging infectious diseases.
The project is a long-term investment, but its direction is clear: modern, connected and resilient laboratory environments will be central to future biosecurity. As planning progresses, the programme will be closely watched by those working across bioscience, diagnostics, public health and high-containment research.
